rs147494925
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_198994.3(TGM6):c.502G>A(p.Val168Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,614,224 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_198994.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGM6 | NM_198994.3 | c.502G>A | p.Val168Met | missense_variant | 4/13 | ENST00000202625.7 | NP_945345.2 | |
TGM6 | NM_001254734.2 | c.502G>A | p.Val168Met | missense_variant | 4/12 | NP_001241663.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM6 | ENST00000202625.7 | c.502G>A | p.Val168Met | missense_variant | 4/13 | 1 | NM_198994.3 | ENSP00000202625.2 | ||
TGM6 | ENST00000381423.1 | c.502G>A | p.Val168Met | missense_variant | 4/12 | 1 | ENSP00000370831.1 | |||
TGM6 | ENST00000477505.1 | n.175-1335G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00162 AC: 247AN: 152220Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000382 AC: 96AN: 251394Hom.: 1 AF XY: 0.000353 AC XY: 48AN XY: 135872
GnomAD4 exome AF: 0.000162 AC: 237AN: 1461886Hom.: 1 Cov.: 31 AF XY: 0.000166 AC XY: 121AN XY: 727246
GnomAD4 genome AF: 0.00161 AC: 246AN: 152338Hom.: 2 Cov.: 32 AF XY: 0.00148 AC XY: 110AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | TGM6: BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 08, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Oct 19, 2017 | BS1, BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. - |
TGM6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 01, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at